Wuhan Keqian Biology Co Ltd (688526) — Capital Reinvestment Ratio
Wuhan Keqian Biology Co Ltd (688526) has a Capital Reinvestment Ratio of 0.07x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥174.36 Million) in capital expenditures (CN¥11.35 Million). Check Wuhan Keqian Biology Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Wuhan Keqian Biology Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Wuhan Keqian Biology Co Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see 688526 cash generation efficiency.
Annual Capital Reinvestment Ratio for Wuhan Keqian Biology Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Wuhan Keqian Biology Co Ltd from 2016 to 2024. See how much free cash does Wuhan Keqian Biology Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | CN¥392.68 Million | CN¥106.94 Million | ▲ +40.2% |
| 2023 | 0.19x | CN¥538.03 Million | CN¥104.50 Million | ▼ -20.0% |
| 2022 | 0.24x | CN¥423.71 Million | CN¥102.85 Million | ▼ -65.6% |
| 2021 | 0.70x | CN¥531.27 Million | CN¥374.45 Million | ▲ +152.7% |
| 2020 | 0.28x | CN¥400.14 Million | CN¥111.60 Million | ▼ -68.6% |
| 2019 | 0.89x | CN¥154.89 Million | CN¥137.74 Million | ▲ +895.7% |
| 2018 | 0.09x | CN¥351.83 Million | CN¥31.42 Million | ▼ -76.6% |
| 2017 | 0.38x | CN¥337.61 Million | CN¥129.11 Million | ▲ +189.7% |
| 2016 | 0.13x | CN¥220.69 Million | CN¥29.13 Million | — |